pcos and glp-1 medications are not approved by the Food Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label Rising use of GLP-1 medications

It is a call to education: there are strong diagrams and mechanistic maps in the article that can be used for teaching, internal innovation workshops, or framing strategy discussions

Three years after announcing her retirement from tennis, Serena Williams has a new job: advertising weight-loss medication

Direct-to-consumer availability and alternative access pathways add further complexity

Without continuous on-site inspections, warning letters, and immediate import alerts, fraudulent schemes like this would remain invisible, exposing millions of American patients to unverified and potentially contaminated medicine

The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats

Fernandes, C